ReviewHead and neck pathology2026
NUT Carcinoma Arising in Stensen's Duct: First Reported Case and Literature Review.
Review in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNUT carcinoma is a rare and aggressive malignancy defined by rearrangements of NUTM1, most commonly with partner BRD4 or BRD3, and carries a dismal prognosis. Carcinoma arising from Stensen's (parotid excretory) duct is itself an exceedingly rare entity, with only 30 previously reported cases spanning diverse morphologies. CASE PRESENTATION: We report the first case of NUT carcinoma arising from Stensen's duct in a 37-year-old female who presented with an enlarging right buccal submucosal mass, initially favored on imaging to represent a chronic inflammatory process. Punch biopsy was originally interpreted as invasive squamous cell carcinoma. Surgical resection revealed a high-grade basaloid carcinoma with abrupt keratinization centered at the parotid papilla with retrograde ductal spread. Immunohistochemistry demonstrated NUT positivity, and fluorescence in situ hybridization confirmed NUTM1 translocation. RNA sequencing identified a BRD4::NUTM1 fusion, establishing the diagnosis of NUT carcinoma. Incidentally, next-generation sequencing identified a BRCA1 mutation, confirmed to be germline on subsequent germline testing. The patient was treated with surgical resection, adjuvant cisplatin chemotherapy, and external beam radiation, with no evidence of disease on PET-CT two months after diagnosis.
conclusionThis case expands the morphologic spectrum of Stensen's duct carcinoma, underscores the challenges in clinical, radiologic, and pathologic interpretation of masses at this site, and suggests a potential association between homologous recombination deficiency and this translocation-associated malignancy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.